GGrantIndex
Sort

78,016 grants matching breast cancer

CIS Research Consortium (CISRC): Years 2006-2011

$1,800,988
Alfred C Marcus · University Of Colorado Denver · P01 · FY2009 · CA

Intervention Trials in Persons at Increased Genetic Risk of Cancer

$1,800,935
Mark H Greene · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes

$1,800,771
Laura J Esserman · University Of California, San Francisco · P01 · FY2021 · CA

Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS

$1,800,256
Jay A Berzofsky · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

$1,800,107
Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Delaware Christiana Care NCORP

$1,798,153
Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2023 · CA

Center for Immunotherapeutic Transport Oncophysics

$1,797,348
Haifa Shen · Methodist Hospital Research Institute · U54 · FY2020 · CA

Phytoestrogens and Progression of Atherosclerosis

$1,796,742
Howard N Hodis · University Of Southern California · U01 · FY2007 · AT

Natural Products Discovery and Characterization Through Network Collaborations

$1,795,568
Lin Du · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Prospective Studies of Diet and Cancer in the AARP Cohort

$1,794,404
Rashmi Sinha · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Center for Nutrient-Gene Interaction in Cancer Prevention

$1,793,809
Stephen Barnes · University Of Alabama At Birmingham · U54 · FY2007 · CA

Chromatin Remodeling and Gene Activation

$1,793,496
David J Clark · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2025 · HD

Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes

$1,793,476
Mikhail Kashlev · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

CHEMOPREVENTION FOR WOMEN AT HIGH RISK OF BREAST CANCER

$1,793,476
University Of Kansas Medical Center · U01 · FY2002 · CA

SOUTHEAST CANCER CONTROL COSORTIUM, INC

$1,793,458
Southeast Cancer Control Consortium · U10 · FY2002 · CA

Descriptive Studies and Record Linkage

$1,793,379
William Anderson · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA

Molecular-Based Therapy for Oral Cancer Prevention

$1,792,413
Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA

Identification of cancer stem cell therapeutic targets

$1,792,219
Michael Clarke · Stanford University · P01 · FY2010 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum

$1,791,871
Amy Trentham-Dietz · University Of Wisconsin-Madison · U01 · FY2023 · CA

Delaware/Christiana Care community Oncology Research Program

$1,791,750
Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2014 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum

$1,791,664
Amy Trentham-Dietz · University Of Wisconsin-Madison · U01 · FY2022 · CA

Roles of Chromatin-modifying Factors in Epigenetic Control of the Genome

$1,791,288
Shivinder S Grewal · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

RISK FACTORS FOR BREAST CANCER AMONG YOUNGER NURSES

$1,790,556
Harvard University (Sch Of Public Hlth) · R01 · FY2002 · CA

Personalized Medicine for Colorectal and Breast Cancer

$1,789,311
Kathryn A Phillips · University Of California, San Francisco · P01 · FY2009 · CA

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

$1,788,456
Franziska Michor · Dana-Farber Cancer Inst · U54 · FY2019 · CA